Peter Flachenecker Selected Research

Peter Flachenecker Research Topics

13	Multiple Sclerosis 01/2024 - 08/2002
4	Fatigue 12/2021 - 04/2004
1	Bradycardia 05/2007
1	Inflammation (Inflammations) 12/2005
1	Chronic Fatigue Syndrome (Myalgic Encephalomyelitis) 02/2005
1	Atrophy 01/2004

3	CannabinoidsIBA 01/2014 - 02/2013
2	Dronabinol (THC)FDA LinkGeneric 05/2018 - 01/2014
2	nabiximols (Sativex)IBA 01/2014 - 01/2014
2	Mitoxantrone (Novantrone)FDA LinkGeneric 03/2012 - 05/2004
2	CytokinesIBA 02/2005 - 04/2004
2	Indicators and Reagents (Reagents)IBA 01/2004 - 08/2002
1	Fingolimod Hydrochloride (FTY720)FDA Link 03/2022
1	CannabidiolIBA 02/2013
1	GlucocorticoidsIBA 12/2005
1	Adrenergic Agents (Adrenergic Drugs)IBA 12/2005
1	Adrenocorticotropic Hormone (ACTH)FDA Link 02/2005
1	Glatiramer Acetate (Copaxone)FDA Link 05/2004
1	Interferon-betaIBA 05/2004
1	Messenger RNA (mRNA)IBA 04/2004
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2004
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 08/2002

10	Therapeutics 01/2024 - 05/2004
1	Endurance Training 12/2021
1	Cognitive Training 01/2012
1	Exercise Therapy (Therapy, Exercise) 01/2012
1	Equine-Assisted Therapy 01/2012
1	Immunomodulation 05/2004